Phosphatidylinositol 4,5-bisphosphate hydrolysis mediates histamine-induced KCNQ/M current inhibition.
The M-type potassium channel, of which its molecular basis is constituted by KCNQ2-5 homo- or heteromultimers, plays a key role in regulating neuronal excitability and is modulated by many G protein-coupled receptors. In this study, we demonstrate that histamine inhibits KCNQ2/Q3 currents in human embryonic kidney (HEK)293 cells via phosphatidylinositol 4,5-bisphosphate (PIP(2)) hydrolysis mediated by stimulation of H(1) receptor and phospholipase C (PLC). Histamine inhibited KCNQ2/Q3 currents in HEK293 cells coexpressing H(1) receptor, and this effect was totally abolished by H(1) receptor antagonist mepyramine but not altered by H(2) receptor antagonist cimetidine. The inhibition of KCNQ currents was significantly attenuated by a PLC inhibitor U-73122 but not affected by depletion of internal Ca(2+) stores or intracellular Ca(2+) concentration ([Ca(2+)](i)) buffering via pipette dialyzing BAPTA. Moreover, histamine also concentration dependently inhibited M current in rat superior cervical ganglion (SCG) neurons by a similar mechanism. The inhibitory effect of histamine on KCNQ2/Q3 currents was entirely reversible but became irreversible when the resynthesis of PIP(2) was impaired with phosphatidylinsitol-4-kinase inhibitors. Histamine was capable of producing a reversible translocation of the PIP(2) fluorescence probe PLC(delta1)-PH-GFP from membrane to cytosol in HEK293 cells by activation of H(1) receptor and PLC. We concluded that the inhibition of KCNQ/M currents by histamine in HEK293 cells and SCG neurons is due to the consumption of membrane PIP(2) by PLC.
Liu
Boyi
B
Department of Pharmacology, Hebei Medical University, Shijiazhuang, Hebei Province, China.
Liang
Huiling
H
Liu
Li
L
Zhang
Hailin
H
D000818:Animals; D002118:Calcium / Q000502:physiology; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism; D004963:Estrenes / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology*; D006801:Humans; D006868:Hydrolysis; D015640:Ion Channel Gating; D051658:KCNQ2 Potassium Channel / Q000502:physiology*; D051659:KCNQ3 Potassium Channel / Q000502:physiology*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D019269:Phosphatidylinositol 4,5-Diphosphate / Q000378:metabolism*; D011738:Pyrilamine / Q000494:pharmacology; D011760:Pyrrolidinones / Q000494:pharmacology; D051381:Rats; D011969:Receptors, Histamine H1 / Q000378:metabolism; D010738:Type C Phospholipases / Q000037:antagonists & inhibitors / Q000378:metabolism*
D004963:Estrenes; D051658:KCNQ2 Potassium Channel; D051659:KCNQ3 Potassium Channel; C496916:KCNQ3 protein, human; C496915:Kcnq2 protein, rat; D019269:Phosphatidylinositol 4,5-Diphosphate; D011760:Pyrrolidinones; D011969:Receptors, Histamine H1; C060229:1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione; D006632:Histamine; D010738:Type C Phospholipases; D011738:Pyrilamine; D002118:Calcium